Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass Diversified Holdings of Class Action Lawsuit and Upcoming Deadlines - CODI
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Krispy Kreme, Inc. - DNUT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cleveland-Cliffs Inc. - CLF
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Open Lending Corporation of Class Action Lawsuit and Upcoming Deadlines - LPRO
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Napco Security Technologies, Inc. of Class Action Lawsuit and Upcoming Deadlines - NSSC
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ibotta, Inc of Class Action Lawsuit and Upcoming Deadlines - IBTA
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everus Construction Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ECG
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bakkt Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - BKKT
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Solaris Energy Infrastructure, Inc. of Class Action Lawsuit and Upcoming Deadlines - SEI
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATNM
-
Pomerantz Law Firm Announces the Filing of a Class Action Against NET Power Inc. and Certain Officers – NPWR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultra Clean Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - UCTT
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Perpetua Resources Corp. of Class Action Lawsuit and Upcoming Deadlines - PPTA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zynex, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZYXI
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Civitas Resources, Inc. and Certain Officers – CIVI
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers – CAR
-
Pomerantz Law Firm Announces the Filing of a Class Action Against BigBear.ai Holdings, Inc. and Certain Officers – BBAI
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against SoundHound AI, Inc. and Certain Officers – SOUN
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Canopy Growth Corporation and Certain Officers – CGC
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
-
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
-
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci
-
Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peri
-
Bitcoin Solaris Unveils Hybrid Consensus Architecture Ahead of Nova App Mining Launch
-
Greywolfe CEO Ron Earley to Headline Oxford Keynote on the Future of AI and E-Commerce
-
Dillard’s, Inc. Announces $0.25 Cash Dividend
-
XRP News: Buy $XDX As XRP Price Goes Up, XenDex Gets Ready To Unveil Its First DEX Version While Presale Nears End
-
XRP News: XenDex Set To Reveal Its First DEX Version While Presale Nears End, Buy $XDX As XRP Price Goes Up
-
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure
-
From Holding to Earning: How JA Mining Is Redefining Passive Crypto Income
-
100x Leverage. No KYC. Double Deposit Bonus. Crypto Futures Trading Made Easy on BexBack
-
JAMining Launches New Cloud Mining Contracts for Trending Altcoins Solana (SOL) and Cardano (ADA)
-
Brain Cancer Canada Awards $68,000 Research Grant for Clinical Trial of Anti-Cancer Vaccine Targeting DIPG, the Most Aggressive Pediatric Brain Cancer
-
BAK Battery Unveils Three Major Product Lines at CIBF 2025, Strategically Shaping the "Core" Engine for Future Development
-
BAK Battery Unveils Three Major Product Lines at CIBF 2025, Strategically Shaping the "Core" Engine for Future Development
-
Bitcoin Solaris to Launch Developer API Suite for Seamless Blockchain App Migration and Deployment
-
Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
-
ORINA Successfully Held Its $ORI Presale on May 15th, 2025 at 8:00 PM
-
Tessera Therapeutics Features New Preclinical Data Demonstrating Progress Across its In Vivo Gene Writing™ Programs and Delivery Platform at the American Society of Gene and Cell Therapy 28th Annua
-
Arcadis' shareholders re-appoint Supervisory Board members and approve dividend
-
First Trust Portfolios Canada Announces Cap, Buffer and Dates of May Buffer ETF
-
SHARC Energy Enters Into Short Term Loan Agreement
-
GoldHaven Clarifies Technical Disclosure
-
SolarMax Technology Reports First Quarter 2025 Financial Results
